<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Axonics Modulation Technologies, Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Axonics Modulation Technologies, Inc.

    Axonics Modulation Technologies, Inc. (NASDAQ:AXNX) is a medical technology company focused on the design, development, and commercialization of innovative and minimally invasive sacral neuromodulation (“SNM”) solutions. SNM therapy is primarily used to treat patients with overactive bladder (“OAB”), fecal incontinence (“FI”) and urinary retention (“UR”). Axonics currently has marketing approvals in Europe, Canada, and Australia for OAB, FI, and UR. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $400,000,000
    • SIC CODE
      3841
    • NIN CODE
      ####
    • LEADERSHIP
      Raymond W. Cohen
    • FOUNDED
      2012
    • EMPLOYEES
      51-100
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    Integra LifeSciences Holdings Corporation

    Integra LifeSciences Holdings Corporation

    Integra LifeSciences, a world leader in medical devices, is dedicated to limiting ...

    Integra LifeSciences, a world leader in medical...

    Filing Type:    PU
    Celsion Corporation

    Celsion Corporation

    Celsion Corporation is a fully integrated biopharmaceutical company focused on dev...

    Celsion Corporation is a fully integrated bioph...

    Filing Type:    PU
    SpringWorks Therapeutics, Inc.

    SpringWorks Therapeutics, Inc.

    SpringWorks Therapeutics is a clinical-stage biopharmaceutical company applying a ...

    SpringWorks Therapeutics is a clinical-stage bi...

    Filing Type:    PU
    Compugen Ltd.

    Compugen Ltd.

    Compugen is a drug discovery company with a unique, broadly applicable, predictive...

    Compugen is a drug discovery company with a uni...

    Filing Type:    PU
    Twist Bioscience Corporation

    Twist Bioscience Corporation

    We are a leading, rapidly growing synthetic biology company that has developed a d...

    We are a leading, rapidly growing synthetic bio...

    Filing Type:    PU
    CAVU Biotherapies, Inc.

    CAVU Biotherapies, Inc.

    CAVU Biotherapies offers a comprehensive solution to prepare for, monitor, and tre...

    CAVU Biotherapies offers a comprehensive soluti...

    Filing Type:    CF
    Establishment Labs Holdings Inc.

    Establishment Labs Holdings Inc.

    Establishment Labs is a global medical technology company focused on improving pat...

    Establishment Labs is a global medical technolo...

    Filing Type:    PU
    AxoGen, Inc.

    AxoGen, Inc.

    Axogen (AXGN) is a global leader in innovative surgical solutions for peripheral n...

    Axogen (AXGN) is a global leader in innovative ...

    Filing Type:    PU
    Pro-Dex, Inc.

    Pro-Dex, Inc.

    Pro-Dex has been in business for over 40 years with our corporate headquarters loc...

    Pro-Dex has been in business for over 40 years ...

    Filing Type:    PU
    ©2025 National Investor Network. All Rights Reserved.